Tenax Therapeutics

Tenax Therapeutics is a pharmaceutical company based in Chapel Hill, North Carolina, with approximately 11 employees. The company is focused on developing novel cardiopulmonary therapies, including oral enteric-coated imatinib (TNX-201) and oral levosimendan (TNX-103), to address unmet medical needs in pulmonary hypertension, a rare and serious disease with limited treatment options.